MEG3 and Alzheimer disease: Furthermore, we developed a DDR-related risk model to precisely predict the clinical outcomes of AD patients based on the 4-DDR-related lncRNA signature (FBXO30-DT, TBX2-AS1, ADAMTS9-AS2, and MEG3) screened by the various machine learning algorithms.